Health Ebitda vs Cost Of Revenue Analysis

HCAT Stock

USD 7.03 0.25 3.69%

Health Catalyst financial indicator trend analysis is much more than just examining Health Catalyst latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Health Catalyst is a good investment. Please check the relationship between Health Catalyst Ebitda and its Cost Of Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Health Catalyst Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Health Catalyst's Ebitda and Cost Of Revenue is -0.48. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Health Catalyst, assuming nothing else is changed. The correlation between historical values of Health Catalyst's Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Health Catalyst are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Health Catalyst's Ebitda and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.48

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Ebitda

Cost Of Revenue

Cost of Revenue is found on Health Catalyst income statement and represents the costs associated with goods and services Health Catalyst provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Health Catalyst's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Health Catalyst current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.At this time, Health Catalyst's Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 1.2 B in 2024, whereas Selling General Administrative is likely to drop slightly above 55.4 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	16.5M	1.7M	7.3M	7.0M
Depreciation And Amortization	37.5M	48.3M	45.2M	27.1M

Interest Expense Depreciation And Amortization

Health Catalyst fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Lease Obligations
Total Assets		0.98	0.71	0.98	0.97	0.02	0.92	0.98	0.98	0.78	-0.92	0.92	0.94	0.98	0.86	0.38	0.98	0.98	0.95	0.97	0.96	0.89	0.94	0.9	-0.61	0.95
Short Long Term Debt Total	0.98		0.71	0.98	0.93	-0.02	0.87	0.99	0.97	0.86	-0.93	0.94	0.89	0.99	0.88	0.42	1.0	0.93	0.98	0.98	0.95	0.93	0.9	0.89	-0.54	0.96
Other Current Liab	0.71	0.71		0.75	0.65	0.48	0.57	0.76	0.64	0.52	-0.56	0.64	0.75	0.76	0.63	0.72	0.7	0.65	0.68	0.7	0.61	0.67	0.56	0.52	-0.31	0.82
Total Current Liabilities	0.98	0.98	0.75		0.94	0.12	0.89	0.99	0.99	0.82	-0.92	0.96	0.91	0.97	0.89	0.5	0.97	0.95	0.98	0.95	0.95	0.87	0.91	0.91	-0.58	0.98
Total Stockholder Equity	0.97	0.93	0.65	0.94		-0.06	0.99	0.91	0.95	0.81	-0.94	0.92	0.87	0.91	0.85	0.35	0.93	0.98	0.9	0.9	0.96	0.78	0.98	0.91	-0.78	0.89
Other Liab	0.02	-0.02	0.48	0.12	-0.06		-0.1	0.1	0.02	-0.31	0.23	0.0	0.18	0.03	-0.18	0.72	-0.05	0.02	0.0	-0.07	-0.05	-0.14	-0.07	0.03	0.12	0.22
Net Tangible Assets	0.92	0.87	0.57	0.89	0.99	-0.1		0.84	0.9	0.78	-0.91	0.91	0.79	0.83	0.81	0.31	0.87	0.96	0.86	0.83	0.94	0.69	0.99	0.91	-0.86	0.81
Property Plant And Equipment Net	0.98	0.99	0.76	0.99	0.91	0.1	0.84		0.97	0.8	-0.9	0.91	0.94	0.99	0.87	0.46	0.98	0.94	0.96	0.98	0.92	0.92	0.87	0.86	-0.48	0.98
Current Deferred Revenue	0.98	0.97	0.64	0.99	0.95	0.02	0.9	0.97		0.83	-0.94	0.96	0.89	0.95	0.88	0.4	0.97	0.96	0.98	0.94	0.96	0.86	0.93	0.94	-0.6	0.95
Net Debt	0.78	0.86	0.52	0.82	0.81	-0.31	0.78	0.8	0.83		-0.92	0.86	0.59	0.79	0.89	0.33	0.86	0.73	0.86	0.8	0.8	0.79	0.77	0.75	-0.55	0.79
Retained Earnings	-0.92	-0.93	-0.56	-0.92	-0.94	0.23	-0.91	-0.9	-0.94	-0.92		-0.93	-0.8	-0.89	-0.96	-0.23	-0.93	-0.9	-0.94	-0.9	-0.91	-0.85	-0.9	-0.85	0.64	-0.86
Accounts Payable	0.92	0.94	0.64	0.96	0.92	0.0	0.91	0.91	0.96	0.86	-0.93		0.79	0.9	0.89	0.45	0.94	0.91	0.98	0.89	0.97	0.8	0.91	0.96	-0.67	0.91
Cash	0.94	0.89	0.75	0.91	0.87	0.18	0.79	0.94	0.89	0.59	-0.8	0.79		0.94	0.79	0.33	0.88	0.92	0.85	0.92	0.84	0.86	0.82	0.75	-0.42	0.9
Non Current Assets Total	0.98	0.99	0.76	0.97	0.91	0.03	0.83	0.99	0.95	0.79	-0.89	0.9	0.94		0.87	0.4	0.99	0.93	0.95	0.99	0.92	0.95	0.87	0.84	-0.47	0.96
Non Currrent Assets Other	0.86	0.88	0.63	0.89	0.85	-0.18	0.81	0.87	0.88	0.89	-0.96	0.89	0.79	0.87		0.22	0.88	0.81	0.92	0.87	0.82	0.86	0.78	0.73	-0.49	0.85
Other Assets	0.38	0.42	0.72	0.5	0.35	0.72	0.31	0.46	0.4	0.33	-0.23	0.45	0.33	0.4	0.22		0.4	0.35	0.41	0.31	0.37	0.23	0.34	0.44	-0.27	0.6
Long Term Debt	0.98	1.0	0.7	0.97	0.93	-0.05	0.87	0.98	0.97	0.86	-0.93	0.94	0.88	0.99	0.88	0.4		0.93	0.97	0.99	0.96	0.94	0.9	0.89	-0.54	0.95
Cash And Short Term Investments	0.98	0.93	0.65	0.95	0.98	0.02	0.96	0.94	0.96	0.73	-0.9	0.91	0.92	0.93	0.81	0.35	0.93		0.91	0.92	0.96	0.81	0.98	0.92	-0.71	0.9
Net Receivables	0.95	0.98	0.68	0.98	0.9	0.0	0.86	0.96	0.98	0.86	-0.94	0.98	0.85	0.95	0.92	0.41	0.97	0.91		0.95	0.95	0.89	0.88	0.91	-0.53	0.95
Good Will	0.97	0.98	0.7	0.95	0.9	-0.07	0.83	0.98	0.94	0.8	-0.9	0.89	0.92	0.99	0.87	0.31	0.99	0.92	0.95		0.92	0.97	0.86	0.83	-0.45	0.93
Common Stock Total Equity	0.96	0.95	0.61	0.95	0.96	-0.05	0.94	0.92	0.96	0.8	-0.91	0.97	0.84	0.92	0.82	0.37	0.96	0.96	0.95	0.92		0.82	0.97	0.97	-0.72	0.89
Common Stock Shares Outstanding	0.89	0.93	0.67	0.87	0.78	-0.14	0.69	0.92	0.86	0.79	-0.85	0.8	0.86	0.95	0.86	0.23	0.94	0.81	0.89	0.97	0.82		0.73	0.69	-0.26	0.87
Short Term Investments	0.94	0.9	0.56	0.91	0.98	-0.07	0.99	0.87	0.93	0.77	-0.9	0.91	0.82	0.87	0.78	0.34	0.9	0.98	0.88	0.86	0.97	0.73		0.95	-0.82	0.84
Long Term Debt Total	0.9	0.89	0.52	0.91	0.91	0.03	0.91	0.86	0.94	0.75	-0.85	0.96	0.75	0.84	0.73	0.44	0.89	0.92	0.91	0.83	0.97	0.69	0.95		-0.75	0.85
Non Current Liabilities Total	-0.61	-0.54	-0.31	-0.58	-0.78	0.12	-0.86	-0.48	-0.6	-0.55	0.64	-0.67	-0.42	-0.47	-0.49	-0.27	-0.54	-0.71	-0.53	-0.45	-0.72	-0.26	-0.82	-0.75		-0.48
Capital Lease Obligations	0.95	0.96	0.82	0.98	0.89	0.22	0.81	0.98	0.95	0.79	-0.86	0.91	0.9	0.96	0.85	0.6	0.95	0.9	0.95	0.93	0.89	0.87	0.84	0.85	-0.48

Click cells to compare fundamentals

Health Catalyst Account Relationship Matchups

Health Catalyst fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	302.4M	577.7M	832.1M	752.3M	701.8M	532.3M
Short Long Term Debt Total	52.7M	195.3M	204.6M	248.0M	249.1M	155.4M
Other Current Liab	11.1M	32.9M	28.3M	19.7M	23.3M	22.6M
Total Current Liabilities	48.2M	88.0M	93.1M	82.5M	89.0M	74.4M
Total Stockholder Equity	200.6M	276.1M	522.1M	425.0M	366.9M	385.3M
Other Liab	3.6M	20.9M	15.8M	226K	203.4K	193.2K
Net Tangible Assets	171.4M	69.4M	247.3M	146.8M	168.9M	177.3M
Property Plant And Equipment Net	8.1M	37.6M	44.4M	42.6M	39.6M	29.7M
Current Deferred Revenue	30.7M	47.1M	56.6M	55.0M	55.8M	44.1M
Net Debt	34.6M	103.3M	11.4M	131.7M	142.8M	149.9M
Retained Earnings	(610.5M)	(725.7M)	(878.9M)	(999.0M)	(1.1B)	(1.2B)
Accounts Payable	3.6M	5.3M	4.7M	4.4M	6.6M	4.3M
Cash	18.0M	92.0M	193.2M	116.3M	106.3M	90.7M
Non Current Assets Total	38.1M	247.9M	323.7M	324.5M	310.6M	208.7M
Non Currrent Assets Other	810K	3.6M	4.5M	3.7M	6.9M	7.3M
Other Assets	810K	28.3M	4.5M	3.7M	1.0	0.95
Long Term Debt	48.2M	169.0M	180.9M	226.5M	228.0M	138.5M
Cash And Short Term Investments	228.3M	270.9M	445.0M	363.5M	317.7M	268.7M
Net Receivables	27.6M	48.3M	48.8M	48.0M	61.2M	43.8M
Common Stock Shares Outstanding	18.7M	39.5M	47.5M	54.1M	56.4M	42.7M
Short Term Investments	210.2M	178.9M	251.8M	247.2M	211.5M	178.0M
Liabilities And Stockholders Equity	302.4M	577.7M	832.1M	752.3M	701.8M	532.3M
Non Current Liabilities Total	53.5M	213.6M	216.9M	244.8M	245.9M	200.9M
Capital Lease Obligations	4.5M	26.3M	23.7M	21.5M	21.0M	16.8M
Other Current Assets	8.4M	10.6M	14.6M	16.3M	12.3M	11.2M
Other Stockholder Equity	508.7M	1.0B	1.4B	(648K)	(745.2K)	(707.9K)
Total Liab	101.7M	301.6M	310.0M	327.3M	334.9M	255.0M
Net Invested Capital	248.8M	445.1M	703.0M	651.5M	595.0M	320.4M
Property Plant And Equipment Gross	8.1M	12.9M	44.4M	42.6M	67.0M	70.3M
Total Current Assets	264.2M	329.8M	508.4M	427.8M	391.2M	323.7M
Accumulated Other Comprehensive Income	72K	61K	(67K)	(648K)	33K	34.7K
Non Current Liabilities Other	326K	19.1M	14.8M	121K	74K	70.3K
Net Working Capital	216.0M	241.8M	415.3M	345.3M	304.4M	249.6M
Short Term Debt	2.8M	2.6M	3.4M	3.4M	3.4M	3.4M

Pair Trading with Health Catalyst

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Health Catalyst position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Catalyst will appreciate offsetting losses from the drop in the long position's value.

Moving together with Health Stock

0.73	DH	Definitive Healthcare	Pair Corr
0.83	LH	Laboratory	Pair Corr

Moving against Health Stock

0.55	CI	Cigna Corp	Pair Corr
0.52	DXCM	DexCom Inc	Pair Corr
0.46	EDAP	EDAP TMS SA	Pair Corr

The ability to find closely correlated positions to Health Catalyst could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Health Catalyst when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Health Catalyst - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Health Catalyst to buy it.

The correlation of Health Catalyst is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Health Catalyst moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Health Catalyst moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Health Catalyst can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Health Catalyst is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Health Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Health Catalyst Stock. Highlighted below are key reports to facilitate an investment decision about Health Catalyst Stock:

How To Invest In Health

Details

Is Health Stock a good investment?

Details

What is Health Catalyst's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.

Note that the Health Catalyst information on this page should be used as a complementary analysis to other Health Catalyst's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Health Stock analysis

When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.

	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Global Correlations Find global opportunities by holding instruments from different markets
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments

Is Health Catalyst's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Health Catalyst. If investors know Health will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.84)

Revenue Per Share

5.189

Quarterly Revenue Growth

0.012

Return On Assets

(0.07)

Return On Equity

(0.28)

The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Catalyst's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Health Ebitda vs Cost Of Revenue Analysis

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Ebitda

Cost Of Revenue

Health Catalyst fundamental ratios Correlations

Health Catalyst Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Health Catalyst fundamental ratios Accounts

Pair Trading with Health Catalyst

Moving together with Health Stock

Moving against Health Stock

Complementary Tools for Health Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Property Plant And Equipment Net	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Net	+ 0.99	Total Current Liabilities
Current Deferred Revenue	+ 0.99	Total Current Liabilities
Net Tangible Assets	+ 0.99	Total Stockholder Equity

Non Currrent Assets Other	- 0.96	Retained Earnings
Net Receivables	- 0.94	Retained Earnings
Retained Earnings	- 0.94	Current Deferred Revenue
Retained Earnings	- 0.94	Total Stockholder Equity
Long Term Debt	- 0.93	Retained Earnings
Accounts Payable	- 0.93	Retained Earnings